Chromaffin cells from the adrenal gland secrete a combination of neuroactive compounds including catecholamines, opioid peptides, and growth factors that have strong analgesic effects, especially when administered intrathecally. Preclinical studies of intrathecal implantation with xenogeneic bovine chromaffin cells in rats have provided conflicting data with regard to analgesic effects, and recent concern over risk of prion transmission has precluded their use in human clinical trials. We previously developed a new, safer source of adult adrenal chromaffin cells of porcine origin and demonstrated an in vivo antinociceptive effect in the formalin test, a rodent model of tonic pain. The goal of the present study was to confirm porcine chromaffin cell analgesic effects at the molecular level by evaluating neural activity as reflected by spinal cord c-Fos protein expression. To this end, the expression of c-Fos in response to intraplantar formalin injection was evaluated in animals following intrathecal grafting of 10 6 porcine or bovine chromaffin cells. For the two species, adrenal chromaffin cells significantly reduced the tonic phases of the formalin response. Similarly, c-Fos-like immunoreactive neurons were markedly reduced in the dorsal horns of animals that had received injections of xenogeneic chromaffin cells. This reduction was observed in both the superficial (I-II) and deep (V-VI) lamina of the dorsal horn. The present study demonstrates that both xenogeneic porcine and bovine chromaffin cells transplanted into the spinal subarachnoid space of the rat can suppress formalinevoked c-Fos expression equally, in parallel with suppression of nociceptive behaviors in the tonic phase of the test. These findings confirm previous reports that adrenal chromaffin cells may produce antinociception by inhibiting activation of nociceptive neurons in the spinal dorsal horn. Taken together these results support the concept that porcine chromaffin cells may offer an alternative xenogeneic cell source for transplants delivering pain-reducing neuroactive substances.
INTRODUCTION
have had promising results in patients with cancerrelated pain intractable to drug therapy (35, 48, 62) . We reported data from a 15-patient phase II clinical trial, The transplantation of chromaffin cells into the central nervous system (CNS) to provide a local source of demonstrating feasibility and safety of chromaffin cell transplants in human subjects (36) , with long-term graft neuroactive substances for reducing pain sensitivity has been investigated in several laboratories over the last survival (7). The practical clinical application of human medullary tissue allografts was, however, hampered by two decades (16, 52) . Intrathecal implants of a variety of adrenal chromaffin cell preparations have produced ro-the complex one-site preparation prior to implantation and, more importantly, by the limited availability of hu-bust and enduring analgesic effects in various rodent pain models including the formalin test (47, 58, 60, 63) , man donor tissue (19, 36) . Xenogeneic bovine chromaffin cells can provide an chronic inflammation (55, 56) , neuropathic pain models (17, 22, 28, 29) , and central pain models (10, 27, 65, 66) .
alternative primary cell source, allowing wide-scale application of this therapeutic approach (54). These cells These preclinical studies provided the rationale to pursue clinical trials in chronic pain patients. Clinical trials can be isolated with high viability and purity and have been shown to survive for prolonged periods in the rat using intrathecal human adrenal medullary allografts 354 SOL ET AL. CNS with only brief and transient use of immunosup-MATERIALS AND METHODS pression (46) . Preclinical studies of intrathecal implanta-Chromaffin Cells: Isolation and Purification tion with xenogeneic bovine chromaffin cells in rats have resulted in conflicting data with regard to analgesic Both isolated porcine and bovine adrenal cells were prepared by collagenase digestion of adrenal medullary effects. Initial studies demonstrated that bovine cell suspensions induced long-lasting analgesic effects on acute tissue, coupled with Percoll gradient purification, but using two different methods. Isolation and purification of nociception in rats without neurotoxicity (54) as well as alleviation of pain behavior in models of peripheral chromaffin cells from bovine adrenal glands were performed essentially as previously described by Bader et neuropathy (17, 29) or central pain (65, 66) . These results were, however, recently questioned by Lindner et al., al. (6) . Porcine chromaffin cells were prepared and maintained in culture according to the method previously de-who failed to obtain analgesic effects following intrathecal bovine chromaffin cell grafting in rodent acute pain scribed by Sagen et al. (54) with only slight modifications (59). In brief, adult bovine (6 months old) and models and in the formalin test (26, (38) (39) (40) . To avoid the risk of prion transmission from bovine cells in clini-porcine (1 year old) adrenal glands were obtained from a local slaughterhouse within 20 min of the animal's cal trials, we developed techniques for isolation and characterization of primary porcine chromaffin cells.
death and placed in ice-cold Locke's buffer solution supplemented with 100 IU/ml penicillin, 100 µg/ml strepto-Pigs are currently the only animals being seriously considered as a source of organs for transplantation to hu-mycin, and 0.125 µl/ml Fungizone (Sigma, France) (PSF) for transport. The glands were trimmed of excess fat and mans (23) . Even if the pig cannot guarantee absolute safety in xenogeneic transplantation (retrovirus), much rinsed in sterile warm (37°C) Locke's solution. During the stages of bovine cellular isolation, the bovine adrenal is known about the infectious agents present in domestic pigs, and identified pathogens can be excluded from ani-vein was cannulated; multiple 1-mm-deep incisions were made in the cortex, which was then rinsed by perfusion mals raised to be pathogen free in semisterile conditions (9, 15, 45) . Previous work in our laboratory has shown with Locke's solution at 37°C to remove any blood from the glands. The medullary tissue was then dissociated by that porcine cells grafted in the rat subarachnoid space can attenuate pain-related behaviors as assessed by the the retrograde perfusion with Locke's digestion buffer containing 0.125% collagenase A (Boehringer Mann-formalin test and may offer a safe alternative xenogeneic cell source for transplants delivering pain-reducing neu-heim) and 0.5% BSA (Sigma, France) using a multichannel peristaltic pump at a rate of 7 ml/min for 1 h at roactive substances (59).
It has been reported that the induction of the immedi-37°C. Each porcine gland was manually perfused, four ate early gene c-fos and c-Fos protein expression in the spinal cord appear to be linked to the presentation of times with warmed Locke's buffer, and then twice with warm Locke's digestion buffer containing 0.2% colla-noxious peripheral stimuli or injury and correlate with pain behaviors (3, 13, 33) . Injection of formalin into the genase A and 0.5% BSA at 30-min intervals using a syringe via the adrenal vein. For each perfusion, the vein hindpaw of rats can evoke a biphasic behavioral response and induce laminar-specific distribution of c-Fos was clamped and the glands were then placed in a container and incubated at 37°C for 30 min to dissociate protein expression, which can be evaluated semiquantitatively by counting the number of c-Fos-positive neu-connective medullary tissue. At the end of digestion, the medulla of both species rons in the lumbar spinal cord (25, 30, 50) . Furthermore, recent findings showed that adrenal medullary trans-were exposed by sharp dissection of the cortical region of the gland and triturated to generate a cell suspension. plants in the subarachnoid space can suppress formalinevoked c-Fos expression in parallel with suppression of The harvested cell suspension was filtered through a nylon mesh screen (217 µm) to remove aggregates of un-nociceptive behaviors (57) . In the present study, we examined the effect of intrathecal chromaffin cell grafts digested tissue. The isolated cells were collected and washed by centrifuge at 70 × g at 20°C for 10 min in on the expression of c-Fos-immunoreactive (c-Fos-IR) neurons induced by formalin injection into the paw.
Locke's buffer. The resulting cells were resuspended and filtered again through an 82-µm nylon mesh before The aims of this study were (i) to provide new evidence of antinociceptive effect of intrathecal porcine purifying the cell population on 48.72% Percoll gradient (Pharmacia Biotech). Following centrifugation for 20 chromaffin cell grafts on expression of c-Fos in the spinal cord induced by plantar injection formalin and to min at 20°C and 20,000 × g, the portion of the gradient containing purified chromaffin cells was harvested by correlate this effect with pain behavior; (ii) to confirm the analgesic effects of porcine chromaffin cells in the aspiration, washed three times by centrifugation at 80 × g and 25°C in Locke's buffer. formalin test and compare this analgesic effect with the bovine cells reference model.
Cell viability was assessed by the trypan blue exclu-sion method. The freshly isolated porcine chromaffin planted into the rat spinal subarachnoid space (L1-L2) via a laminectomy at the lumbar level using the method cells (PCC) and bovine chromaffin cells (BCC) were resuspended (0.5 × 10 6 /ml) and cultured in Dulbecco's previously described by Sagen et al. (53) . Porcine striate muscle was removed from the animal's abdominal areas, modified Eagle medium/Ham's F-12 (DMEM/F12, 1:1, Invitrogen, Cergy Pontoise, France) supplemented with placed in ice-cold Hank's buffer solution, and then cut into small pieces (less than 0.5 mm 3 ) at +4°C; a total of 5% (v/v) fetal bovine serum, antibiotics (PSF), and antimitogenic agents (cytosine βD arabinofuranoside and 5 flu-6 mg of tissue (the weight of two rat adrenal glands) was transplanted via the dural slit and gently pushed oro 5 deoxyuridine; Sigma Alrich, France). Primary cells were plated either on plastic T25 culture flasks (Falcon, away from the opening with a stylet. To implant cultured PCC and BCC suspensions, 6 × 10 6 cells/dish) or 12-well culture plates (Falcon, Polylabo, Ullkrich, France, 0.5 × 10 6 cells/well) accord-chromaffin cells were removed from their tissue culture flasks following a 2-day stabilization period by gentle ing to the experiment and maintained in a 95% humidified air, 5% CO 2 at 37°C. The culture medium was re-enzymatic digestion (Trypsin-EDTA, Gibco BRL). The harvested cells were first washed in medium with 10% newed every 4 days. For implantation in vivo, cells were prepared from 2-day cultures by gentle digestion with FBS and then washed and resuspended in HBSS without serum. Trypan blue exclusion estimated cell viability at trypsin-EDTA followed by washing, counting, and centrifugation. The cells were resuspended with 10 µl of >90% prior to implantation. Chromaffin cells (10 µl, 10 6 cells) were injected into the subarachnoid space with a HBSS with 1 × 10 6 cells for one implantation per rat.
Hamilton 20-µl syringe via polyethylene tubing (PE-10) Animals: Care and Cell carefully advanced rostrally to 1 cm above the dural in-Transplantation Surgery cision. After 2 min, the tubing was slowly withdrawn to prevent backflow of cells. Following all intraspinal Experiments were performed in adult male Sprague-Dawley rats (Elevage Janvier, Le Genest-St-Isle, France), surgical procedures, the overlying muscle and the skin were sutured. Rats were observed in the recovery room weighing 225-250 g at the start of the experiment. All experimental procedures on animals were reviewed and until they had opened their eyes and were upright. Animals exhibiting motor abnormalities resulting from sur-approved by the local Research Committee before the study was initiated. The study was conducted in an ani-gical procedures (<5%) were sacrificed. mal facility in accordance with the ethical guidelines of the International Association for the Study of Pain (67).
Behavioral Testing For pre-and postsurgical animal care, animals were group housed two to three per standard cage, in a tem-Three weeks after chromaffin cell implantation, all animals in the six groups (n = 7 per group) were as-perature-controlled room (21 ± 1°C) on a 12:12-h light/ dark cycle, with rat food and water ad lib. In our study, sessed on the formalin test. All behavioral testing was conducted by an experimenter blinded to group classifi-porcine striate muscle (PSM) xenograft was used as control graft material. Rats were randomly assigned to cation and drug dose. Surgical procedures were performed by separate experimenters not involved with be-the following groups: G1-intraperitoneal (IP) injection of morphine at 5 mg/kg (n = 7), G2-IP injection havioral testing. In a separate room from the behavioral testing room, morphine groups received an injection of of morphine at 10 mg/kg (n = 7), G3-IP injection of NaCl 0.9% (morphine negative control; n = 7), G4-morphine (5 or 10 mg/kg, IP) 10 min before being injected with the formalin. All rats were injected with 50 intrathecal (IT) implantation of porcine striate muscle xenograft control from adult donors (chromaffin cells µl of 2.5% formalin solution SC in the plantar surface of their right hindpaw with a 30-gauge needle. Immediately negative control, PSM; n = 7), G5-IT injection of purified adult bovine adrenal chromaffin cells (BCC 10 6 / following the injection, the rats were individually placed in a Plexiglas chamber and observed for a 60-min pe-rat; n = 7), G6-IT injection of purified adult porcine adrenal chromaffin cells (PCC 10 6 /rat; n = 7). All the riod. Pain intensity was rated according to numerical behavior categories defined by Dubuisson et al. (18) , and animals in each group were immunosuppressed by cyclosporin A (Sandoz, France), 10 mg/kg, IP, daily data were manually recorded continuously on a polygraph (Gould) at a speed of 1 mm/s. The weighted com-from 1 day before implantation until 2 weeks after implantation.
posite pain score (CPS ) was calculated using the following formula: T 2 + 2T 3 /300 based on Watson et al. All surgical procedures were performed using aseptic technique and anesthesia [IP injection of a mixture of (61) where T 2 and T 3 represent the time in seconds spent in categories 2 (injected paw is elevated) or 3 (the ani-150 mg/kg ketamine and 10 mg/kg xylazine (Bayer, France), supplemented as necessary]. Both control por-mal licks, bites, or shakes the affected paw) during each 300-s epoch, respectively. cine muscle and chromaffin cell suspensions were im-
Immunohistochemical Detection
fied. All the c-Fos-immunoreactive (c-Fos-IR) nuclei were analyzed without considering the intensity of the of Spinal c-Fos Neurons staining. To study the laminar distribution of c-Fos-IR nuclei, four regions were arbitrarily defined in the spinal Three weeks following cell transplantation, formalinevoked c-Fos expression in the rat spinal dorsal horn gray matter of the L3-L5 segments: superficial laminae of the dorsal horn (corresponding to laminae I-II), nu-was evaluated by anti-c-Fos immunohistochemistry as previously described (14). Intraplantar diluted formalin cleus proprius (laminae III-IV), neck of the dorsal horn (laminae V-VI), and the ventral horn (laminae VII-X), was injected in the right hindpaw of the animals. The morphine group received an injection of morphine (5 or according to the cytoarchitectonic organization of the spinal cord (42, 43, 51) . For each animal, two parameters 10 mg/kg, IP) 10 min before being injected with the formalin. Of the seven animals in each group (G1-G6), were considered: 1) the total number of c-Fos-IR nuclei in the gray matter for 10 sections through L4-L5 seg-five animals were randomly selected for c-Fos immunocytochemistry. Seventy-five minutes following formalin ments (means ± SEM), and 2) the number of c-Fos-IR nuclei per specific laminar region of the spinal gray mat-injection, the animals were deeply anaesthetized with pentobarbital (60 mg/kg, IP). Five minutes later (80 min ter in these 10 sections (means ± SEM). The investigator responsible for plotting and counting the c-Fos-IR nuclei after noxious stimulation) they were perfused intracardially with 300 ml heparinized (5000 U/L) PBS (pH 7.4), was blind to the experimental situations. followed by 500 ml 4% paraformaldehyde in 0.1 M Immunohistochemical Analysis phosphate buffer (PB) at pH 7.4. The spinal cords from the thoracic to sacral regions were carefully dissected Following perfusion, postfixation, and cryoprotection performed as described above, the spinal cord (L2-L6) along with intact dura, then removed and postfixed for 4 h in the same fixative, then cryoprotected overnight of two rats from each experimental transplant group was cut into 5-µm sections, embedded in Tissue-Tek (Inter-by 30% buffered sucrose (in PB) at 4°C. Serial frontal frozen sections of the lumbar enlargement (L2-L6) were chim, France), and kept at −70°C for subsequent tyrosine hydroxylase (TH) and met-enkephaline (MET) la-cut (40 µm) on a sliding microtome and collected at intervals of 120 µm in PB, as free-floating sections to beling and assessment of graft survival in the rat subarachnoid space. be processed immunohistochemically. After incubation in a blocking solution of 3% normal goat serum (NGST) Seven micrometer serial transverse frozen sections were cut on a cryostat and mounted on gelatin slides. in PBST (0.1 M PBS and 0.3% Triton X-100), sections were immunostained for c-Fos-like protein according to
Labeling was employed to screen for chromaffin cells in 1 slide out of 10, and the slides with chromaffin cells the avidin-biotin-peroxidase method. Tissue sections were incubated for 16 h at room temperature in the pri-were selected for immunohistochemistry (IHC), with mouse anti-TH and anti MET monoclonal antibodies, mary polyclonal rabbit c-Fos anti-serum (Tebu, sc-52, diluted at 1:60,000 in NGST), then washed and incu-(1:1000, Sigma). Immunohistochemistry was performed with a DAKO LSAB2 kit (Dako, Trappes, France) ac-bated in biotinylated goat anti-rabbit IgG secondary antibody (Vector Laboratory, 1:200, Burlingame, CA) for 1 cording to the manufacturer's specifications. Sections were then counterstained with hematoxylin, mounted in h at room temperature, followed by washing and incubation for 1 h in avidin-biotin-horseradish peroxidase com-Eukitt medium, and assessed. plex of the ABC standard Elite kit (AbCys, France). Fi-Data Analysis nally the c-Fos protein-like immunoreactivity (Fos-LI) was visualized using the peroxidase kit (Vector VIP, For statistical analysis, data are expressed as mean ± SEM. In the formalin test, weighted pain scores were AbCys, France). Once the reaction was completed, sections were mounted on gelatin-subbed slides (10 sec-compared between the different groups using a two-way ANOVA for repeated measures. To perform the statisti-tions per slide and per rat), air dried, dehydrated through a graded alcohol series, xylene treated, and coverslipped cal analysis for c-Fos-LI neuron counts, the cell count was transformed because of a highly asymmetric distri-with Eukitt mounting medium (Interchim, Montluçon, France). The rat spinal cord sections from the same ex-bution. Based on statistical theory, data from cell counts follow a Poisson rather than a normal distribution. If the perimental series were immunoreacted at the same time for statistical comparison. Tissue sections were first ex-data are transformed by the square root of each count then the resultant data will have a distribution that is amined using light field microscopy at 4× to determine the segmental level according to Molander et al. (43) , as nearly normal. Analysis was carried out by repeated measure ANOVA variance analysis. well as the gray matter landmarks. The sections were then examined using a Zeiss inverted microscope, and Post hoc comparisons (pairwise differences between groups) were performed using a Bonferroni multiple labeled c-Fos neurons were photographed and quanti- (laminae VII-X). Neurons positive for c-Fos protein were identified by dark violet-labeled nuclei (Fig. 2) .
RESULTS
The intraplantar injection of formalin produced a characteristic increase in the number of c-Fos-IR neu- In contrast, c-Fos-IR nuclei were virtually absent in the contralateral dorsal horn (Fig. 2) , and no groups; porcine striated muscle tissue transplanted animals (IT PSM, G4) and NaCl 0.9% IP injected animals significant difference could be noted when compared to the ipsilateral side in sham-operated nonstimulated rats (IP NaCl, G3), similar to responses described by others. An initial phase (phase 1), demonstrated in Figure 1 , (data not shown). In the control groups, as shown in Figure 2 , c-Fos-IR nuclei were predominantly located in was apparent within the first minute postinjection, then rapidly subsided during the next 5-10 min when the ani-both the medial region of the superficial laminae I-II (>77% of the total ipsilateral c-Fos-IR) and the deep mals became quiescent. A more prolonged second phase began approximately 15 min postformalin, peaked at laminae (V-VI) (<13% of the total c-Fos-IR) with a few c-Fos-labeled neurons (<9%) in the nucleus proprius 30-40 min, and subsided thereafter (phase 2).
In phase 1 (1-10 min postinjection), attenuation of (III-IV) or in the ventral horn (VII-X). In the animals with adrenal porcine or bovine transplants, expression the CPS was observed only in the morphine 10 mg/kg group (G2) ( p < 0.05). There was no significant differ-of c-Fos was also only observed on the side ipsilateral to the formalin injection. The distribution analysis re-ence in this phase between animals with morphine 5 mg/ kg (G1) or xenogeneic adrenal medullary grafts (G5, sults ( Fig. 3) showed that most of these neurons were observed in both the medial region of the superficial G6) and their respective control porcine striate muscle (G4) or NaCl (G3).
lamina (I-II) and the deep lamina (V-VI). The total number of formalin-evoked c-Fos-IR nuclei (laminae In phase 2 (15-60 min postinjection) morphine 5 and 10 mg/kg produced a robust dose-dependent analgesic I-X) was significantly decreased in the both BCC and PCC implanted groups compared with the control group effect compared with the two negative control groups G3 and G4 ( p < 0.05 to p < 0.001), shown in Figure 1A .
of rats grafted with PSM (8.9 ± 1.1, 12.3 ± 1.2, 40 ± 1.5, respectively; p < 0.001 for both) (Fig. 3 ). The ability of Figure 1A shows the CPS in response to intraplantar formalin injections in the animals with porcine chromaf-both porcine and bovine cell transplants to attenuate formalin-evoked c-Fos-positive cells in the lumbar spinal fin cells and PSM control transplants. CPS was significantly reduced in the animals with porcine adrenal med-cord was slightly higher than the pharmacological efficacy of 5 mg/kg IP morphine (laminae I-X) (16 ± 1.0, ullary transplants (PCC) during phase 2 ( p < 0.05 to p < 0.001) compared with control transplants (PSM). p < 0.01) (Fig. 3) . The density of c-Fos-labeled neurons was markedly reduced in both superficial and deeper We observed that the analgesic effect of PCC transplanted group was similar to the morphine group (5 mg/ laminae for both cell-implanted groups and morphineinjected groups (Fig. 3 ). kg) because there was no significant difference between PCC and morphine 5 mg/kg in phase 2 (Fig. 1A) . Fi-To obtain an estimate of the magnitude of this decreased pattern, the mean number of c-Fos-positive neu-nally, we did not observe significant differences in pain behavior between BCC and PCC for the two phases of rons in the adrenal transplant groups was calculated for corresponding regions in the control animals. This com-the test (Fig. 1B, p > 0.1 
). parison revealed that xenogeneic porcine and bovine Effect of Intrathecal Chromaffin Cell Transplants cells were effective in attenuating the number of formaon Formalin-Induced Spinal Neuron c-Fos Expression
lin-evoked c-Fos-IR nuclei in the superficial laminae ( p < 0.001) ( Fig. 3) as well as in the deep dorsal horn Three weeks after cell implantation, rats were sacrificed and were assessed using c-Fos immunohistochem-compared to PSM control ( p < 0.001) (Fig. 3) . The reduction in formalin evoked c-Fos-IR nuclei in superfi-istry (IH) to reflect spinal neuron-evoked activity in the lumbar spinal enlargement, between the L3 and L5 seg-cial laminae was 76% and 71% for BCC and PCC, respectively. In the deep dorsal laminae, reduction was ments. To study the laminar distribution of c-Fos-IR nuclei, four regions of the gray matter were defined accord-92% for BCC and 90% for PCC. A nonsignificant dif- ference between the effects of porcine and bovine cells filtration or other blood cells was observed in the graft sites of these animals. There was no apparent compres-on the number of formalin-evoked c-Fos-IR nuclei remained statistically the same either in the deep dorsal sion or damage to the host spinal cord by these implantation procedures. horn or in the superficial laminae.
Immunohistological Staining and Graft Survival DISCUSSION
Our study indicates that chromaffin cell grafts pro-Two of the seven animals of each group were randomly chosen and autopsied 21 days after the transplan-duce antinociception in formalin-evoked pain. This effect is in accordance with previous results that demon-tation following behavioral testing. The viability and distribution of the implanted cells were studied by im-strated potent antinociceptive effects of chromaffin cells in a wide variety of acute and chronic pain models in munohistochemical labeling for both tyrosine hydroxylase (TH, the first limiting enzyme of catecholamine rodents (16, 22, 27, 29, 65) . Our laboratory and others previously reported that adrenal medullary tissue fragment synthesis) and met-enkephalin (MET). All the animals' spinal cords, in the transplanted groups G5 and G6, were allografts or isolated chromaffin cell xenografts implanted in the rat spinal subarachnoid space alleviated found to have chromaffin cells with positive TH and MET labeling (Fig. 4) . Cells were distributed predomi-pain in both phases of the formalin test (57) (58) (59) (60) . In the present study, there was a nonsignificant trend for sup-nantly at the lumbar level. An illustration of porcine chromaffin cell morphology in the spinal subarachnoid pression of formalin evoked-behavior by xenogeneic chromaffin cell grafts in the acute phase 1, and a signifi-space 3 weeks after implantation is shown in Figure 4 . Chromaffin cells apparently remain healthy and were cant suppression in the entire tonic phase 2. These contradictory results may be due a variety of experimental found in groups, lying in the subarachnoid space between the cord and the dura. They did not appear to parameters and linked to the lack of statistical power in some phases of the present study. In particular, there integrate with the host spinal cord parenchymal tissues. Neither tyrosine hydroxylase immunoreactivity nor met-was a low number of rats per group (n = 7) and only two analyzable time points (at 0 and at 10 min post-enkephalin was observed in the control groups. No apparent immunological response such as macrophage in-formalin injection) in phase 1. The absence of signifi- cant analgesic effect of 5 mg/kg of IP morphine in phase tonic pain, even with high doses of cells (10 6 cells/rat). These authors challenge the usefulness of this experi-1 supports this hypothesis.
However, the subcutaneous injection of dilute forma-mental treatment. Variations in transplantation or animal testing procedures between laboratories may account for lin into rat hindpaw is a unique test in that it produces a biphasic response, consisting of an early phase during some of these differences in preclinical studies (57, 59, 64) . the first 5 min after formalin injection and a later phase starting at 15 min and lasting for 40-50 min. Tradition-In the present study, in order to confirm the analgesic effect of intrathecal chromaffin cell grafts, we used c-ally, the first phase has been viewed as being due to an acute direct chemical activation of nociceptors in the Fos expression as a measure of nociceptive processing occurring during the formalin test. C-Fos protein is ex-periphery and the second phase as being due to an ensuing inflammatory response or to a central sensitization.
pressed within activated neurons following noxious stimuli. To investigate spinal nociceptive processing, the The later moderate inflammatory response (phase 2) characterized by persistent shaking or licking of the in-c-Fos expression pattern, used as a marker for neuronal activity or sensitivity to the stimulation, is well docu-jected paw that occurs 20-60 min after injection is thought to bear a closer resemblance to clinical pain mented (31, 33, 44) . Presence of c-Fos in the cell nucleus can be documented by classical immunohistochemical (18) . One other explanation for the lack of efficacy of chromaffin cell grafts in phase 1 could be that the basal techniques using specific antibodies to c-Fos protein.
This technique has the advantage of high cellular resolu-and continuous release of small quantities of analgesic substances from the transplants may be sufficient to at-tion along with high sensitivity for extremely low protein concentrations (33, 41) . Of greatest interest is the tenuate lower intensity tonic pain in the second phase of the formalin test, but higher release of these agents from possibility of correlating behavioral observations in the awake animals with subsequent immunocytochemical transplanted cells seems to be required to reduce the high intensity acute pain in the first phase of the test evidence of neuronal activation in the central nervous system as reflected by the number of c-Fos immunola-(59). This is further supported Siegan et al., who reported a relatively greater suppression of phase 2 by ad-beled spinal neurons. All modalities of peripheral nociceptive stimuli studied (cutaneous: chemical, mechani-renal medullary allogeneic transplants in the formalin test compared to phase 1 (57) . Recently, the analgesic cal, thermal, and visceral) have been shown to induce increases of spinal c-Fos protein expression (32, 37, 44) . effects of intrathecal adrenal transplants have been questioned. In the rat formalin test, Lindner et al. (26, (38) (39) (40) The formalin response is accompanied by characteristic induction of the immediate early gene c-fos and expres-failed to demonstrate any analgesic effect of allo-or xenogeneic bovine chromaffin cell grafting on acute or sion of c-Fos protein within 1-2 h of injection of forma-lin (2, 4, 25, 50) . In the present study, we observed a study, reduction of c-Fos expression was observed in both superficial and deep laminae of the dorsal horn, but widely distributed increase of c-Fos protein expression 80 min after the formalin injection, which occurred ipsi-to a greater extend in the deeper regions (>90%). These results are in agreement with behavioral studies that laterally and was located in the L3-L5 spinal segments corresponding to the somatotopic distribution of the acti-showed a greater analgesic effect of cell grafts on phase 2 of the formalin test. However, the absolute number of vated primary afferents of the hindpaw, consistent with previous reports (12,50). The distribution of neurons ex-c-Fos-IR neurons was lower than reported in previous studies in all groups, with or without cell grafts. Con-pressing c-Fos-IR after formalin noxious stimulation was increased predominantly in superficial lamina (I-II) versely, the number of labeled neurons in layers I and II was proportionately greater (>75%). Preliminary results and neck of the dorsal horn (V-VI). This laminar pattern of c-Fos-IR nuclei is in accordance with the electro-by Sagen et al., confirmed in our laboratory, have shown that chromaffin cell grafts have an analgesic effect that physiological data demonstrating that a high proportion of superficial neurons are driven by peripheral noxious is maximal at the beginning of the second phase of the formalin test at 20-40 min. Expression of neuronal c-stimuli and with anatomical evidence that the majority of nociceptive primary afferents terminate in the superfi-Fos-IR appears at between 30 and 60 min, reaching a maximum at 2-4 h (2) . We based our experimental para-cial dorsal horn of the spinal cord (8). On the other hand, we found very few c-Fos-IR neurons (<2 cells/section) digms on these data, and chose to sacrifice animals at 80 min post-formalin injection in the hope of getting on the side contralateral to nociceptive stimulation or in layers III-IV known for a neuronal population activated higher specificity, whereas in most studies, animals are sacrificed at 2-4 h. Presley et al. showed, that after in-by only nonnociceptive cutaneous stimulation. This would strongly suggest that this experimental paradigm traplantar formalin injection, c-Fos-IR nuclei are rapidly identified ipsilaterally, mainly in the superficial dorsal is appropriate and specific for assessing possible attenuation of noxious stimuli by cell grafting.
horn (laminae I-II), with numbers in deep laminae (V-VI) increasing over time postinjection (50). Bullitt et al. We found a significant reduction in the number of c-Fos-IR neurons following formalin stimulation of the rat demonstrated that brief noxious stimulation evoked predominantly superficial c-Fos expression, whereas with hindpaw by both porcine and bovine intrathecal chromaffin cell grafts. Our results are consistent with a pre-an increased duration of stimulation, akin to the second phase of the formalin response, there is additional c-Fos vious study that demonstrated a correlation between analgesic activity and a reduction of formalin-evoked expression in the deep laminae of the dorsal horn (13). Furthermore, under conditions of chronic inflammation, spinal c-Fos protein expression following intrathecal chromaffin cell allografts (58) . The authors demon-such as polyarthritis, c-Fos is expressed selectively in deep laminae neurons and is correlated with the hyperal-strated that adrenal medullary transplants may produce antinociception by inhibiting activation of nociceptive gesia and inflammatory signs (1, 55) . Despite a number of studies using c-Fos expression neurons in the spinal dorsal horn. Chromaffin cells synthesize and secrete a number of agents that can poten-to study nociceptive processes, mainly in the spinal cord, this application remains controversial. One of the tially contribute to suppression of formalin pain responses and c-Fos expression during the first and second main drawbacks of this strategy is the nonspecific nature of c-Fos activation. This was already apparent in the phase. These include opioid peptides, catecholamines, and the peptide histogranin (a putative NMDA antago-study by Hunt et al., who found spinal c-Fos expression in superficial layers (I-II) following nociceptive cutane-nist and nitric oxide synthase inhibitor). It has been suggested that different patterns of activity are generated ous stimulation, but also, to a lesser degree, activation of deeper layers (III-IV) following nonnociceptive stim-during the two phases of the formalin response, and that these two phases contribute equally to the expression of ulation (33) . Conversely, other studies have not found c-Fos activation following nonnociceptive stimuli (11,21, c-Fos in the superficial dorsal horn (5). Moreover, the distribution of the c-Fos depends on the nature and time 44). Our study is in agreement with the latter authors, in the same animals. 355-365; 1998. In summary, the present study supports the concept 
